Massive prostate surgery registry aims to find best treatment
NCT ID NCT07159165
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is a large registry that will collect information from 10,000 men in Turkey who are having minimally invasive surgery for an enlarged prostate. The goal is to track which procedures are used, how well they work, and any complications. By gathering this real-world data, doctors hope to learn which surgical techniques are most effective for different patients.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this registry could provide real-world evidence to guide which surgical technique works best for different patients, potentially improving treatment guidelines.
- What could go wrong
- This is an observational registry, not a controlled trial, so it cannot prove one surgery is better than another. Results may be affected by differences in how each hospital performs the procedures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 10,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Jul 2035
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult male patients (≥18 years) diagnosed with benign prostatic obstruction (BPO) and scheduled to undergo minimally invasive surgical treatment at participating centers. The registry will include consecutive eligible patients treated with procedures such as transurethral resection of the prostate (TURP), holmium laser enucleation of the prostate (HoLEP), thulium laser enucleation of the prostate (ThuLEP), Rezum®, or other contemporary surgical techniques, according to routine clinical practice.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male patients ≥ 18 years old * Diagnosis of BPO with clinical indication for minimally invasive surgery * Signed informed consent * Availability of complete baseline and follow-up data Exclusion Criteria: * No informed consent * Missing essential preoperative or follow-up data
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Benign prostatic hyperplasia with lower urinary tract symptoms are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Ondokuz Mayıs University
Samsun, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.